Survodutide
Price range: $143.00 through $286.00
Survodutide’s efficacy is primarily manifested in two aspects: weight loss and improved liver health. Its mechanism involves the simultaneous activation of glucagon and GLP-1 receptors. Specifically, through a dual agonist effect, it reduces appetite and increases satiety on the one hand, and increases energy expenditure and directly improves liver fibrosis on the other.
Description
Survodutide’s efficacy is primarily manifested in two aspects: weight loss and improved liver health. Its mechanism involves the simultaneous activation of glucagon and GLP-1 receptors. Specifically, through a dual agonist effect, it reduces appetite and increases satiety on the one hand, and increases energy expenditure and directly improves liver fibrosis on the other.
Weight Management
Increased Satiety and Reduced Appetite: As a GLP-1 receptor agonist component, it effectively suppresses appetite, making users feel full.
Increased Energy Expenditure: As a glucagon receptor agonist component, it increases energy expenditure and may be the first drug to simultaneously reduce appetite and increase hepatic energy expenditure.
Clinical Trial Results: Phase II clinical trial data showed that overweight or obese subjects experienced weight loss of up to 19%.
Liver Health
Improved MASH: In patients with metabolic dysfunction-associated steatohepatitis (MASH), Survodutide showed the potential to significantly improve MASH, with up to 83.0% of patients achieving significant improvement compared to placebo.
Improvement of Liver Fibrosis: In adult MASH patients at stages F1, F2, and F3, up to 52.3% showed significant improvement in fibrosis.
Direct Action on the Liver: The glucagon receptor agonist component directly affects the liver, contributing to the improvement of liver fibrosis.
Summary: Survodutide is a dual agonist under development that shows significant potential in weight management and improving liver diseases such as MASH by binding the action of glucagon and GLP-1 receptors.
Additional information
| Weight | N/A |
|---|---|
| Dimensions | N/A |
| FOMAT | 10Bottlex5mg, 10Bottlex10mg |





